SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-276404
Filing Date
2022-11-03
Accepted
2022-11-03 07:45:37
Documents
15
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d347911d8k.htm   iXBRL 8-K 29477
2 EX-99.1 d347911dex991.htm EX-99.1 74516
7 GRAPHIC g347911g1103000744293.jpg GRAPHIC 4784
  Complete submission text file 0001193125-22-276404.txt   284954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20221103.xsd EX-101.SCH 3936
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20221103_def.xml EX-101.DEF 14138
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20221103_lab.xml EX-101.LAB 23511
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20221103_pre.xml EX-101.PRE 15164
9 EXTRACTED XBRL INSTANCE DOCUMENT d347911d8k_htm.xml XML 6654
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 221356280
SIC: 2834 Pharmaceutical Preparations